Singapore markets open in 1 hour 57 minutes

Mankind Pharma Limited (MANKIND.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
2,060.65-77.25 (-3.61%)
At close: 03:29PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 856.52B
Enterprise value 823.90B
Trailing P/E 44.84
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.30
Price/book (mrq)9.15
Enterprise value/revenue 7.97
Enterprise value/EBITDA 29.10

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 323.86%
S&P500 52-week change 326.25%
52-week high 32,488.65
52-week low 31,680.50
50-day moving average 32,180.94
200-day moving average 32,058.01

Share statistics

Avg vol (3-month) 319.5k
Avg vol (10-day) 311.73k
Shares outstanding 5400.64M
Implied shares outstanding 6403.76M
Float 879.61M
% held by insiders 177.09%
% held by institutions 113.18%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 18.51%
Operating margin (ttm)19.93%

Management effectiveness

Return on assets (ttm)12.32%
Return on equity (ttm)22.58%

Income statement

Revenue (ttm)103.35B
Revenue per share (ttm)257.98
Quarterly revenue growth (yoy)18.90%
Gross profit (ttm)N/A
EBITDA 25.35B
Net income avi to common (ttm)19.13B
Diluted EPS (ttm)47.68
Quarterly earnings growth (yoy)65.10%

Balance sheet

Total cash (mrq)34.56B
Total cash per share (mrq)86.25
Total debt (mrq)2.07B
Total debt/equity (mrq)2.16%
Current ratio (mrq)3.10
Book value per share (mrq)233.66

Cash flow statement

Operating cash flow (ttm)21.52B
Levered free cash flow (ttm)12.79B